Ionis Pharmaceuticals, Inc. (IONS)
60.36
-0.69
(-1.13%)
USD |
NASDAQ |
Aug 31, 16:00
60.35
-0.01
(-0.02%)
After-Hours: 20:00
Ionis Pharmaceuticals Net Income (TTM) : -564.78M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -564.78M |
| March 31, 2026 | -326.58M |
| December 31, 2025 | -380.99M |
| September 30, 2025 | -255.99M |
| June 30, 2025 | -267.87M |
| March 31, 2025 | -457.68M |
| December 31, 2024 | -453.55M |
| September 30, 2024 | -358.55M |
| June 30, 2024 | -365.48M |
| March 31, 2024 | -384.50M |
| December 31, 2023 | -366.02M |
| September 30, 2023 | -409.02M |
| June 30, 2023 | -308.60M |
| March 31, 2023 | -328.45M |
| December 31, 2022 | -269.29M |
| September 30, 2022 | 7.405M |
| June 30, 2022 | -28.07M |
| March 31, 2022 | -3.809M |
| December 31, 2021 | -28.51M |
| September 30, 2021 | -609.21M |
| June 30, 2021 | -563.36M |
| March 31, 2021 | -520.04M |
| December 31, 2020 | -480.06M |
| September 30, 2020 | 79.28M |
| June 30, 2020 | 134.33M |
| Date | Value |
|---|---|
| March 31, 2020 | 161.82M |
| December 31, 2019 | 305.68M |
| September 30, 2019 | 405.03M |
| June 30, 2019 | 366.24M |
| March 31, 2019 | 319.74M |
| December 31, 2018 | 214.94M |
| September 30, 2018 | -91.53M |
| June 30, 2018 | -78.65M |
| March 31, 2018 | -25.17M |
| December 31, 2017 | -5.39M |
| September 30, 2017 | 24.25M |
| June 30, 2017 | 39.10M |
| March 31, 2017 | -14.68M |
| December 31, 2016 | -86.56M |
| September 30, 2016 | -183.85M |
| June 30, 2016 | -226.98M |
| March 31, 2016 | -134.48M |
| December 31, 2015 | -88.28M |
| September 30, 2015 | 14.21M |
| June 30, 2015 | 23.31M |
| March 31, 2015 | -24.42M |
| December 31, 2014 | -38.98M |
| September 30, 2014 | -94.31M |
| June 30, 2014 | -92.21M |
| March 31, 2014 | -90.25M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| Biogen, Inc. | 834.60M |
| BridgeBio Pharma, Inc. | -702.02M |
| Vertex Pharmaceuticals, Inc. | 4.405B |
| Arrowhead Pharmaceuticals, Inc. | -272.12M |